Ratnakar Securities Pvt. Ltd.

RAINBOW CHILDREN'S MEDICARE LTD.

NSE : RAINBOWBSE : 543524ISIN CODE : INE961O01016Industry : Hospital & Healthcare ServicesHouse : Private

BSE1343.8528.05 (+2.13 %)

PREV CLOSE ( ) 1315.80

OPEN PRICE ( ) 1323.30

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 9020

TODAY'S LOW / HIGH ( )1322.15 1352.00

52 WK LOW / HIGH ( )775.05 1488.45

BSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 07-08 1998

Management Info

Ramesh Kancharla - Chairman Ramesh Kancharla - Managing Director

Registered Office

Address 8-2-120/103/1,Survey No. 403, Road No. 2,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040-49692218

Email info@rainbowhospitals.in

Website www.rainbowhospitals.in

Registrars Details

K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)

Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad

Listing : BSE, NSE

NEWS

08Mar Rainbow Childrenâ€™s Medicare adds 50-
Rainbow Childrenâ€™s Medicare has added a around 50-bed additional block..

02Mar JSW Steel, Torrent Power and Hindustan
JSW Steelâ€™s step down wholly owned subsidiary -- JSW Steel Italy SRL(J..

01Mar Rainbow Childrenâ€™s Medicare launches
Rainbow Childrenâ€™s Medicare has launched its new state-of-art 80 beds..

24Feb Rainbow Children's Medicare submits an
Pursuant to Regulation 30 of the SEBI (Listing obligations and Disclosur..

25Jan Rainbow Childrenâ€™s Medicare inaugura
Rainbow Childrenâ€™s Medicare has inaugurated a new around 90 beds spoke..

Financials

in Millions

	QTR Dec 23	ANNUAL 23
Net Profit	611.41	2058.93
Gross Profit	825.45	2728.34
Operating Profit	1219.98	4132.61
Net Sales	3217.9	11139.9

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Dr Agarwals Eye Hsp (BSE) 3564.55 (2.56%)	M.Cap ( in Cr)1675.34
Dr. Lal Pathlabs (BSE) 2387.05 (2.45%)	M.Cap ( in Cr)19926.58
Kovai Medical Center (BSE) 4193.40 (1.09%)	M.Cap ( in Cr)4588.53
Metropolis Health. (BSE) 1805.55 (0.76%)	M.Cap ( in Cr)9249.62
Narayana Hrudayalay (BSE) 1275.85 (1.02%)	M.Cap ( in Cr)26073.37

Shareholding Pattern

	PROMOTERS	49.83%
	NON-INSTITUTION	11.37%
	MUTUAL FUNDS/UTI	10.54%
	FI/BANKS/INSURANCE	1.95%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
SBI Healthcare Opp ...	3.80
Motilal Oswal Small...	3.40
PGIM India Small Ca...	3.34
HSBC Focused Fund-Reg(G)	3.31
WOC Pharma and Heal...	2.76
HSBC Consumption Fu...	2.50

attention investors
kyc
ipo
ibt trading

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

Ratnakar Securities

Smart Quotes

RAINBOW CHILDREN'S MEDICARE LTD.

Filing complaints on SCORES Easy & quick

RISK DISCLOSURES ON DERIVATIVES